Skip to main content

Table 3 parameters of metabolism, hemostasis endogenous fibrinolysis and blood rheology

From: Hemostatic risk factors in patients with coronary artery disease and type 2 diabetes - a two year follow-up of 243 patients

 

clinical event

without clinical event

p-value

n = 88

n = 150

 

total cholesterol (mg/dl)

243 ± 49

238 ± 44

n.s.

hdl - cholesterol(mg/dl)

44 ± 11

45 ± 12

n.s.

ldl - cholesterol(mg/dl)

182 ± 49

173 ± 41

n.s.

triglycerides (mg/dl)

209 ± 143

185 ± 113

n.s.

lipoproteine (a) (mg/dl)

32 ± 39

34 ± 41

n.s.

uric acid (mg/dl)

5,8 ± 1,6

6,6 ± 1,7

n.s.

glucose (mg/dl)

108 ± 51

92 ± 35

<0,05

tissue -plasminogenactivator (μg/l)

9,3 ± 3,5

8,2 ± 3,0

<0,05

plasminogenaktivator-inhibitore (U/ml)

4,9 ± 2,5

4,9 ± 3,0

n.s.

fibrinogen (mg/dl)

330 ± 65

319 ± 70

n.s.

plasma viscosity (mPa × s-1)

1,3 ± 0,1

1,3 ± 0,2

n.s.

red blood cell aggregation M (E)

7,7 ± 2,4

7,5 ± 2,3

n.s.

red blood cell aggregation M1 (E)

12,4 ± 2,9

12,3 ± 3,0

n.s.

hematocrit (%)

43,6 ± 3,2

43,1 ± 3,1

n.s.